Quick Answer
BIOREGENX, INC. reported Gross Profit of $1.66 million for fiscal year 2024.
BIOREGENX, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $1.66M | -28.3% |
| 2023 | $2.31M | +5382.6% |
| 2022 | $42.2K | -78.7% |
| 2021 | $198.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $426.4K | -11.5% | +21.0% |
| June 30, 2025 | $352.5K | -25.0% | -13.2% |
| March 31, 2025 | $406.0K | +5.7% | -15.7% |
| September 30, 2024 | $481.6K | -15.7% | +2.5% |
| June 30, 2024 | $469.9K | -21.5% | +22.3% |
| March 31, 2024 | $384.2K | — | -32.7% |
| September 30, 2023 | $571.2K | — | -4.5% |
| June 30, 2023 | $598.3K | — | — |
- BIOREGENX, INC. showed a decrease of -28.3% in Gross Profit compared to the prior fiscal year.
- Over the 2021–2024 period, BIOREGENX, INC.’s gross profit has grown by 737.5% (from $198.0 thousand to $1.66 million).
- The most recent figure is from BIOREGENX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: